This panel will address strategies for handling valuation disputes and other post-closing adjustments arising from cannabis M&A, looking at before-the-fact transactional considerations and after-the-fact litigation solutions. We will also consider the availability of state-law restructuring and turnaround remedies given the absence of federal bankruptcy protection for cannabis companies; it’s a hybrid event.
As the cannabis industry grows and more states allow cannabis licensing, the ethical duties that cannabis attorneys must balance have grown more complicated. These ethical duties require lawyers to balance and re-evaluate their duty to zealously advocate for their clients with the duty of candor, their duties to all of their cannabis clients – and, at times, their belief systems and why they entered cannabis law originally. Join our expert panel to discuss these duties and how they try to balance them in their cannabis practices and emerge with a renewed sense of how to identify issues that may challenge competing duties as attorneys and ways to resolve these conflicts.
Effective strategies for success depend on contracts. Given the complexity of the legal and regulatory landscape around cannabis, operators and ancillary providers must be creative and unique to achieve maximum results within the bounds of what is permissible. This panel will break down the many ways in which cannabis companies can effectively and creatively contract to achieve their goals.
Federal Cannabis Legislation and Regulation. Attend this session for an overview of developments in federal cannabis legislation and regulation. Panelists will address new bills, reintroductions, and what is likely to move.
Attendees will leave this panel with a deeper understanding of the current hemp and CBD legislation and proposed legislative solutions to current regulatory and legal challenges facing the hemp and hemp-derived cannabinoid industries. Panelists will do a deep dive into current legislative proposals, as well as approaches for the 2023 Farm Bill.
Pathways to Ending Federal Prohibition: An Overview of Descheduling & Rescheduling. In 2022, President Biden directed his administration to conduct a review of the status of cannabis under the Controlled Substances Act. This session examines the review process for descheduling and rescheduling and their potential impacts.
Interstate Commerce in Theory: Raich, the Dormant Commerce Clause, and How Challenges to Social Equity Programs Could Impact Interstate Cannabis Commerce. From the Supreme Court's decision in Raich v. Gonzales to recent challenges regarding state-level importing and exporting restrictions, the Constitution's Commerce Clause has played a critical role in shaping the legal cannabis industry. Our panel of legal experts will dive deep into the precedential cases and discuss recent dormant Commerce Clause challenges to the constitutionality of social equity programs nationwide.
Canada: What Federal Legalization Looks Like 4 years Later and What Have We Learned. This panel explores and reflects on the legislative updates, regulatory challenges, and business opportunities that have evolved over the past four years of federal cannabis legalization in Canada.
Regulating Cannabinoids: A Comparative Analysis of Intoxicating and Non-Intoxicating Models. The focus of this session is to provide an overview of the Farm Bill and dive into a comparative analysis of regulatory models for intoxicating and non-intoxicating cannabinoids across the country.